BURLINGTON, N.C., June 14, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, is pleased to share that its executive vice president and chief marketing officer, Amy Summy, has been awarded the inaugural Forrester Customer Obsession Leadership Award, recognizing senior executives who put customers at the center of everything they do to accelerate business growth, retain customers and enable greater employee engagement.
"It is an honor to be recognized by Forrester on behalf of all of our employees who put our customers at the center of everything we do," said Amy Summy, Labcorp's executive vice president, chief marketing officer and consumer business lead. "Putting the customer at the center serves as an essential part of our mission to improve health and improve lives."
Labcorp's teams supported over 150 million patient interactions in 2022, along with supporting clinical trials that delivered 90% of the new FDA drug approvals in 2022. Under Summy's leadership, the marketing team brings the value of Labcorp's science and technology to a broad spectrum of customers, who require insights, seamless experiences and relevant content to make clear and confident decisions.
"Labcorp upholds a long history and culture of innovation," said Adam Schechter, chief executive officer of Labcorp. "We take immense pride in Amy's recognition and leadership. Her work to advance Labcorp as a customer-centered, insights-driven organization has made a positive impact on the customer experience and strengthened our brand. We are proud of Amy's recognition and the efforts of all of our employees who deliver for our customers every day."
About Forrester
Forrester (Nasdaq: FORR) is one of the most influential research and advisory firms in the world. We help leaders across technology, customer experience, digital, marketing, sales, and product functions use customer obsession to accelerate growth. Through Forrester's proprietary research, consulting, and events, leaders from around the globe are empowered to be bold at work — to navigate change and put their customers at the center of their leadership, strategy, and operations. Our unique insights are grounded in annual surveys of more than 700,000 consumers, business leaders, and technology leaders worldwide; rigorous and objective research methodologies, including Forrester Wave™ evaluations; 100 million real-time feedback votes; and the shared wisdom of our clients. To learn more, visit Forrester.com.
About Labcorp
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With more than 80,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14.9 billion in FY2022. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.
Last Trade: | US$218.77 |
Daily Change: | -1.81 -0.82 |
Daily Volume: | 137,498 |
Market Cap: | US$18.300B |
April 02, 2025 February 06, 2025 December 17, 2024 November 04, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load